HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2228821Generated: October 29, 2026
Ethyl chloroformate → (5-Bromo-3-pyridinyl)methanol
https://huagongshe.com/reaction/2228821
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl chloroformate | HCID 10928 | — |
| Reactant | 5-Bromonicotinic acid | HCID 88707 | — |
| Reactant | lithium aluminium hydride THF | HCID 68718528 | — |
| Product | (5-Bromo-3-pyridinyl)methanol | HCID 2784733 | — |
Reaction Steps
The manner in which certain 5-substituted-3-pyridyl compounds of the present invention can be synthetically produced can vary. For example, 3-(5-bromo-3-pyridyl)-containing compounds can be prepared using a combination of synthetic techniques known in the art. 2-[3-(5-bromopyridiyl)]-substituted analogs of the 1-azatricyclo[3.3.1.13,7]decanes can all be prepared starting from 5-bromonicotinic acid, which is commercially available from Aldrich Chemical Co. The 5-bromonicotinic acid is converted to the mixed anhydride with ethyl chloroformate and reduced with lithium aluminum hydride/tetrahydrofuran (THF) at −78° C., to afford 5-bromo-3-hydroxymethylpyridine, as reported by Ashimori et al., Chem. Pharm. Bull. 38:2446 (1990). Alternatively, the 5-bromonicotinic acid is esterified in the presence of sulfuric acid and ethanol, and the intermediate ester is reduced with sodium borohydride to yield 5-bromo-3-hydroxymethylpyridine, according to the techniques reported in C. F. Natatis, et al., Org. Prep. and Proc. Int. 24:143 (1992). The resulting 5-bromo-3-hydroxymethylpyridine can then be converted to the 5-bromo-3-aminomethylpyridine utilizing a modification of the techniques of O. Mitsunobu, Synthesis 1 (1981), or via treatment of 5-bromo-3-hydroxymethylpyridine with thionyl chloride and reaction of the resulting 5-bromo-3-chloromethylpyridine with aqueous ammonia/ethanol, according to North et al., WO 95/28400. 5-Bromo-3-aminomethylpyridine can be converted to 1-aza-2-[5-bromo-(3-pyridyl)]tricyclo[3.3.1.13,7]decane using procedures analogous to those described hereinbefore for the preparation of 1-aza-2-(3-pyridyl)tricyclo[3.3.1.13,7]decane.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06417359B1 |
|---|
| Source dataset | uspto-grants-2002_07 |
|---|
| ORD ID | ord-6cb28d1b7a90462aa8eb3640cccf2289 |
|---|
| Source note | uspto-grants-2002_07 |
|---|